Federico Grossi - Net Worth and Insider Trading
Federico Grossi Net Worth
The estimated net worth of Federico Grossi is at least $3 Million dollars as of 2024-09-22. Federico Grossi is the Chief Medical Officer of Apellis Pharmaceuticals Inc and owns about 94,884 shares of Apellis Pharmaceuticals Inc (APLS) stock worth over $3 Million. Details can be seen in Federico Grossi's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Federico Grossi has not made any transactions after 2023-01-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Federico Grossi
Federico Grossi Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Federico Grossi owns 1 companies in total, including Apellis Pharmaceuticals Inc (APLS) .
Click here to see the complete history of Federico Grossi’s form 4 insider trades.
Insider Ownership Summary of Federico Grossi
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
APLS | Apellis Pharmaceuticals Inc | 2023-01-05 | See Remarks |
Federico Grossi Latest Holdings Summary
Federico Grossi currently owns a total of 1 stock. Federico Grossi owns 94,884 shares of Apellis Pharmaceuticals Inc (APLS) as of January 5, 2023, with a value of $3 Million.
Latest Holdings of Federico Grossi
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
APLS | Apellis Pharmaceuticals Inc | 2023-01-05 | 94,884 | 32.50 | 3,083,730 |
Holding Weightings of Federico Grossi
Federico Grossi Form 4 Trading Tracker
According to the SEC Form 4 filings, Federico Grossi has made a total of 37 transactions in Apellis Pharmaceuticals Inc (APLS) over the past 5 years, including 0 buys and 37 sells. The most-recent trade in Apellis Pharmaceuticals Inc is the sale of 2,500 shares on January 5, 2023, which brought Federico Grossi around $121,975.
Insider Trading History of Federico Grossi
- 1
Federico Grossi Trading Performance
Federico Grossi Ownership Network
Ownership Network List of Federico Grossi
Ownership Network Relation of Federico Grossi
Federico Grossi Owned Company Details
What does Apellis Pharmaceuticals Inc do?
Who are the key executives at Apellis Pharmaceuticals Inc?
Federico Grossi is the See Remarks of Apellis Pharmaceuticals Inc. Other key executives at Apellis Pharmaceuticals Inc include See Remarks James George Chopas , Chief Operating Officer Pascal Deschatelets , and Chief Financial Officer Timothy Eugene Sullivan .
Apellis Pharmaceuticals Inc (APLS) Insider Trades Summary
Over the past 18 months, Federico Grossi made no insider transaction in Apellis Pharmaceuticals Inc (APLS). Other recent insider transactions involving Apellis Pharmaceuticals Inc (APLS) include a net sale of 320,688 shares made by Pascal Deschatelets , a net sale of 493,087 shares made by Cedric Francois , and a net sale of 102,839 shares made by Timothy Eugene Sullivan .
In summary, during the past 3 months, insiders sold 37,742 shares of Apellis Pharmaceuticals Inc (APLS) in total and bought 0 shares, with a net sale of 37,742 shares. During the past 18 months, 1,334,201 shares of Apellis Pharmaceuticals Inc (APLS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,334,201 shares.
Apellis Pharmaceuticals Inc (APLS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Apellis Pharmaceuticals Inc Insider Transactions
Federico Grossi Mailing Address
Above is the net worth, insider trading, and ownership report for Federico Grossi. You might contact Federico Grossi via mailing address: C/o Apellis Pharmaceuticals, Inc., 6400 Westwind Way, Suite A, Crestwood Ky 40014.